ONE-WAYOngoing theme · still written in the latest filings

PRI-724 Fibrosis Clinical Development

An individual drug-candidate development program for PRI-724, under which efficacy was confirmed in Phase I and Phase IIa trials targeting cirrhosis and MASH, with Phase II clinical trials in the fibrosis area continuing.

Companies1How many companies write about this.

Threads1One company can carry more than one thread here.

PeriodFY2024 →Still being written about.

Directionhelps1 helps · 0 hurts · 0 flat